Institutional investors surge into DexCom amid FDA approval of over-the-counter glucose sensor for children

Fresh filings reveal several institutional investors, including Man Group, are building new positions in DexCom as the FDA broadens access to its Stelo glucose sensor for children, intensifying competition in the growing continuous glucose monitoring sector. DexCom is drawing renewed…















